Prasannan Subhita, Davies Giles, Bochner Melissa, Kollias James, Malycha Peter
Breast, Endocrine and Surgical Oncology Unit, Royal Adelaide Hospital, University of Adelaide, North Terrace, Adelaide, SA 5000, Australia.
ANZ J Surg. 2007 Sep;77(9):774-7. doi: 10.1111/j.1445-2197.2007.04227.x.
Surgeon-performed ultrasound (SPU) and (99m)Tc-sestamibi (SM) scanning can be used alone or in combination in patients with primary hyperparathyroidism to select cases suitable for minimally invasive parathyroidectomy (MIP). The aim of the study was to evaluate SPU and SM and to determine the reliability they provide the surgeon in planning and carrying out MIP.
The study was a prospective analysis of 130 patients with primary hyperparathyroidism who had preoperative localization with SPU and SM at a tertiary referral centre between 2003 and 2006. All ultrasound scans were carried out by one surgeon, followed by correlative sestamibi scan and a further 'on operating table' ultrasound to reassess the lesion and mark the operative site. Selection criteria for MIP were a positive SPU and SM, although a positive SPU or SM allowed the surgeon to focus on the nominated side. SPU and SM localizations were correlated to the operative findings.
One hundred and thirty patients underwent both SPU and SM. There were 97 women and 33 men, with a mean age of 59 years. SPU alone identified the abnormal parathyroid in 103 cases (sensitivity 82%; positive predictive value 96.3%). SM alone identified the abnormal gland in 102 cases (sensitivity 79%; positive predictive value 99%). In 88 patients, the SPU and SM were concordant, and 94% had successful MIP. SPU and SM were both negative in 13 patients, and all these patients had bilateral neck exploration.
SPU in the hands of an experienced surgeon in association with sestamibi is a reliable tool for the preoperative localization of parathyroid adenomas and facilitates a minimally invasive procedure.
在原发性甲状旁腺功能亢进症患者中,外科医生实施的超声检查(SPU)和(99m)锝-甲氧基异丁基异腈(SM)扫描可单独使用或联合使用,以选择适合微创甲状旁腺切除术(MIP)的病例。本研究的目的是评估SPU和SM,并确定它们在为外科医生制定和实施MIP计划时提供的可靠性。
本研究是对2003年至2006年间在一家三级转诊中心接受SPU和SM术前定位的130例原发性甲状旁腺功能亢进症患者进行的前瞻性分析。所有超声扫描均由一名外科医生进行,随后进行相关的甲氧基异丁基异腈扫描以及进一步的“手术台上”超声检查,以重新评估病变并标记手术部位。MIP的选择标准是SPU和SM均为阳性,尽管SPU或SM阳性也可使外科医生将重点放在指定的一侧。SPU和SM定位与手术结果相关。
130例患者均接受了SPU和SM检查。其中女性97例,男性33例,平均年龄59岁。单独SPU在103例中识别出异常甲状旁腺(敏感性82%;阳性预测值96.3%)。单独SM在102例中识别出异常腺体(敏感性79%;阳性预测值99%)。在88例患者中,SPU和SM结果一致,其中94%的患者成功进行了MIP。13例患者的SPU和SM均为阴性,所有这些患者均接受了双侧颈部探查。
在经验丰富的外科医生手中,SPU联合甲氧基异丁基异腈是甲状旁腺腺瘤术前定位的可靠工具,并有助于实施微创手术。